Merck's recent decline is due to reduced profit guidance and FDA decisions, but shares are at a support level. Read why I ...

New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and ...

Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning ...

A trade group representing large compounding pharmacies sued the FDA over its removal of a widely prescribed Lilly diabetes ...

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to ...

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.

John Jacobs wasn’t interested when a recruiter approached him about the Novavax Inc. CEO job in 2022. Jacobs was head of ...

The combination of immunotherapy blockbuster drug Keytruda from Merck and the experimental mRNA ... While no one knows if the COVID-19 success of mRNA science can be replicated for cancer, it ...

The health news update discusses Washington state's abortion pill stockpile as a safeguard, BioAge's successful IPO, a ...

The global lipid nanoparticles market is on track to grow from USD 271.8 million in 2024 to USD 350.5 million by 2029, driven ...

A persistent infection could explain why some people experience long COVID symptoms, according to a new study led by researchers at Brigham and Women’s Hospital. The team found evidence of persistent ...

Most investors unaware of the huge breakthroughs happening in biotech right now. But new technologies such as cancer-killing ...